Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Non Operating Income (2015 - 2018)

Updated

Atossa Therapeutics (ATOS) reported Non Operating Income of $104.00 for Q3 2018, compared with -$283.00 a year earlier.

Analysis

Atossa Therapeutics (ATOS) Non Operating Income (2015 - 2018) Analysis & Trends

Over the twelve months ended Sep 30, 2018, Atossa Therapeutics' Non Operating Income came in at -$83.00; for FY2015, it came in at $431.00, up 65.8% from FY2014.

  • By year, Non Operating Income came in at $260.00 in FY2014.
  • The Q3 2018 figure ranks as the highest quarterly Non Operating Income since Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 104.00
Mar 31, 2018 59.00
Sep 30, 2017 -283.00
Mar 31, 2017 37.00
Sep 30, 2016 1.76 Mn
Dec 31, 2015 -115,677.00
Sep 30, 2015 69,350.00
Jun 30, 2015 48,659.00
Mar 31, 2015 -1,415.00
API Access

Atossa Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATOS&period=max&api_key=YOUR_API_KEY